Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Company Wrapped up Its First Month of Robotics Deliveries as It Marches Forward Towards Its 200-unit Delivery Target for the First Delivery Quarter
FFAI will hold its fourth quarter and fiscal year 2025 earnings call and release its Q4 2025 and full-year financial results on April 1 at 7:30 a.m. Beijing Time... Read more.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The Company Wrapped up Its First Month of Robotics Deliveries as It Marches Forward Towards Its 200-unit Delivery Target for the First Delivery Quarter
FFAI will hold its fourth quarter and fiscal year 2025 earnings call and release its Q4 2025 and full-year financial results on April 1 at 7:30 a.m. Beijing Time... Read more.
Faraday Future to Report Its Fourth Quarter and Full Year 2025 Financial Results and Host an Investor Call on March 31, 2026
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based... Read more.
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ TOKYO–(BUSINESS... Read more.
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient... Read more.
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Merck’s WINREVAIR met primary endpoint of change in pulmonary vascular resistance (PVR), significantly improving the ability of blood to flow through the lungs... Read more.
ONON Investors Have Opportunity to Join On Holding AG Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$ONON—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
Super Micro Computer, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – SMCI
LOS ANGELES–(BUSINESS WIRE)–$SMCI—The DJS Law Group reminds investors of a class action lawsuit against Super Micro Computer, Inc. (“Super Micro”... Read more.
ImmunityBio, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – IBRX
LOS ANGELES–(BUSINESS WIRE)–$IBRX—The DJS Law Group reminds investors of a class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or... Read more.
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SMCI—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.